Compare MakeMyTrip Ltd (MMYT) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MakeMyTrip Ltd vs Altria Group Inc — how do they compare? MakeMyTrip Ltd trades at $42.6 (market cap $4.09B), while Altria Group Inc trades at $71.28 (market cap $119.25B). The key difference: Altria Group Inc is far larger — about 29.2× MakeMyTrip Ltd's market cap, and Altria Group Inc pays a 6.22% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold MakeMyTrip Ltd for 12 Days and Altria Group Inc for 154 Days on average.
| MMYT | MO | |
|---|---|---|
Market Cap | $4.09B | $119.25B |
Volume | 1,828,010 | 11,178,169 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $94.43 | $74.92 |
52-Week Low | $36.30 | $54.72 |
Typical Hold Time | 12 Days | 154 Days |
Enterprise Value | $4.75B | $141.46B |
Dividend Yield | — | 6.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MakeMyTrip (MMYT) trades at $43.41 with minimal daily movement (+0.09%). The stock shows mixed technical signals with a bearish overall trend but oversold RSI readings. Fundamentally, the company maintains strong revenue growth (2025: $978M, 2026: $1.1B) and a robust gross margin of 73.45%, though net margins have compressed from 9.72% to 3.22%. Recent earnings show volatility with one beat and two misses in the last four quarters.
Wall Street maintains strong bullish sentiment with a $77 consensus price target (72.7% buy ratings), representing 77% upside potential. Key risks include declining profitability margins, significant debt increase forecasted for 2026, and competitive pressures in the travel sector. The planned Indian subsidiary IPO could unlock value but execution remains critical.
Altria Group (MO) trades at $69.39, up 1.22% today, near the analyst consensus price target of $69.71. The stock shows a bullish technical trend with strong moving average signals, while oscillators remain neutral. Fundamentally, the company maintains robust profitability with a 39% net income margin and strong cash flow, though revenue has been slightly declining. Recent earnings have been mixed, with one beat and two misses in the last three quarters. A high dividend yield of approximately 6.6% is supported by 60 consecutive annual increases, but the balance sheet shows negative shareholder equity.
The outlook for MO balances income appeal against structural challenges. The high dividend and bullish analyst consensus (61.5% buy ratings) offer value for income investors, but risks include declining core tobacco sales, regulatory pressures on nicotine products, and a leveraged balance sheet. Earnings growth and smoke-free product adoption are critical for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
